Cov 2 Sars Test

SD Dengue Duo NS1 Ag and IgG/IgM test

11FK45 10 tests/kit
EUR 147.4

Human IgG antibody Laboratories manufactures the cov 2 sars test reagents distributed by Genprice. The Cov 2 Sars Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Cov products are available in stock. Specificity: Cov Category: 2 Group: Sars Test

TruStrip RDT Human IgG Rapid test cards, 25/pk

1 Pk
EUR 351.6

TA Anti-Trophoblast Membrane Ab IgG ELISA test

96T/Box Ask for price
Description: ELISA based test for quantitative detection of TA Anti-Trophoblast Membrane Ab IgG

SD Bioline HCV 25 test, duluent, acpp, lancets and swabs

25 tests/kit
EUR 178.2

Disintegration Test Solution 2(pH 6.8)(10x)

5L
EUR 68.6

Disintegration Test Solution 2(pH 6.8)(10x)

20L
EUR 192.5

SARS-CoV-2 Spike Antibody

1 mg
EUR 1000
Description: SARS-CoV-2 Spike Antibody, Recombinant Human

SARS-CoV-2 Spike Antibody

1 mg
EUR 1000
Description: SARS-CoV-2 Spike Antibody, Recombinant Human

Sars Test information

SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein

10-415 0.1 mg
EUR 651.3
Description: Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV.

SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein

10-416 0.1 mg
EUR 651.3
Description: The Severe Acute Respiratory Syndrome (SARS) Coronavirus (CoV) is an enveloped, positive-stranded RNA viruses that can cause a severe respiratory disease. Its genome consists of a ∼30 kb linear, non-segmented, capped, polycistronic, polyadenylated RNA molecule, the first two-third of which is directly translated into two large polyproteins. These two polypeptides are processed into 16 non-structural proteins (nsps), forming the replicase complex, which is active in the cytoplasm in close association with cellular membranes. Nsp1 was proved to be able to suppress host gene expression by promoting host mRNA degradation and was involved in cellular chemokine deregulation. This virus evades the host innate immune response in part through the expression of its non-structural protein (nsp) 1, which inhibits both host gene expression and virus- and interferon (IFN)-dependent signaling. Thus, nsp1 is a promising target for drugs, as inhibition of nsp1 would make SARS-CoV more susceptible to the host antiviral defenses.

SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein

10-417 0.1 mg
EUR 651.3
Description: May participate in viral replication by acting as a ssRNA-binding protein.

SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein

10-425 0.1 mg
EUR 651.3
Description: The positive-stranded RNA genome of the coronaviruses is translated from ORF1 to yield polyproteins that are proteolytically processed into intermediate and mature nonstructural proteins (nsps). SARS-CoV 2 polyproteins incorporate 16 protein domains (nsps). The putative non-structural protein 2 (nsp2) of SARS-CoV plays an important role in viral transcription and replication, and is an attractive target for anti-SARS drug development.

SARS-CoV-2 (COVID-19) ORF8 Recombinant protein

10-436 0.1 mg
EUR 695.4
Description: May play a role in host-virus interaction.

SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein

10-002 0.1 mg
EUR 714.3
Description: LOCUS: QHD43422 121aa linear VRL 18-MAR-2020

SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein

20-187 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein

20-188 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein

SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein

20-192 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein

20-212 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP9 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein

20-213 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein

20-214 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP7 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein

20-215 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP5 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein

20-217 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP2 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein

20-218 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein

SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein

20-237 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) ORF8 Recombinant Protein

SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein

20-250 0.1 mg
EUR 726.9
Description: SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein